EUVIMEDEUVIMED entdecken
Open Access

Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation

Robert Wang iD, Feng Wang iD, Nicole DeBruyne iD, Xinjun Ji iD, Nicole M Engelhardt iD, Joseph Jee-Hwan Park iD, Amber Notaro iD, Samantha Gaerlan iD, Ryan Park iD, Matthew J Schultz iD, Sheila Clever, Elizabeth M McCormick iD und 12 weitere

Science Advances · 17.04.2026 · 12 (16)

DOI: 10.1126/sciadv.ady9895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 17.04.2026. Verfasst von Robert Wang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Center for Computational and Genomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Rare Diseases, Sequence Analysis, RNA, Genetic Variation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health, The Rocket Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnosing rare genetic diseases remains a major challenge despite widespread clinical testing. Long-read RNA sequencing (RNA-seq) offers a powerful approach to capturing the effects of genetic variants on the transcriptome, yet challenges with sequencing coverage, cost, tissue selection, and scalability have limited its clinical adoption. To address this, we developed STRIPE (Sequencing Targeted RNAs Identifies Pathogenic Events), a targeted long-read RNA-seq–based strategy for rare disease diagnosis and variant interpretation. STRIPE enables deep sequencing of full-length transcripts for any customized disease-specific gene panel such that a wide range of clinically informative readouts, including transcript aberrations and sequence variants, can be detected at haplotype-level resolution. Applying STRIPE to 88 individuals spanning two major rare disease groups, we accurately reidentified known pathogenic variants and revealed their transcript consequences, including many unexpected ones. For 8 of 15 splice site region variants, we observed more complex RNA processing defects beyond single exon skipping or cryptic splice site activation. Notably, we find that donor splice site variants frequently activate cryptic intronic polyadenylation sites, leading to premature transcript termination. Leveraging unique strengths of long-read RNA-seq, STRIPE also resolved variants of uncertain significance and uncovered disease-causing variants in five previously undiagnosed individuals. Overall, STRIPE is a powerful, adaptable, and scalable strategy with broad potential to improve clinical variant interpretation and advance genetic diagnosis of rare diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesSequence Analysis, RNAGenetic VariationHumansHigh-Throughput Nucleotide SequencingRNA Splice SitesHaplotypes

Substanzen

RNA Splice Sites

Autor:innen und Institutionen

  • Center for Computational and Genomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Graduate Group in Cell and Molecular Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Biochemical Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55902, USA.

ORCID-Profile: Robert Wang, Feng Wang, Nicole DeBruyne, Xinjun Ji, Nicole M Engelhardt, Joseph Jee-Hwan Park, Amber Notaro, Samantha Gaerlan, Ryan Park, Matthew J Schultz, Elizabeth M McCormick, Kelsey Keith, Bobby G Ng, Kathryn E Kadash-Edmondson, Hudson H Freeze, Christina T Lam, Eva Morava, Ingo Helbig, Marni J Falk, Rebecca D Ganetzky, Andrew C Edmondson, Lan Lin, Yi Xing

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • The Rocket Fund

Zitieren

APA

Wang, R., Wang, F., DeBruyne, N., Ji, X., Engelhardt, N. M., Park, J. J., Notaro, A., Gaerlan, S., Park, R., Schultz, M. J., Clever, S., McCormick, E. M., Keith, K., Ng, B. G., Kadash-Edmondson, K. E., Freeze, H. H., Lam, C. T., Morava, E., Helbig, I., …, & Xing, Y. (2026). Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation. Science Advances, 12(16). https://doi.org/10.1126/sciadv.ady9895

Vancouver

Wang R, Wang F, DeBruyne N, Ji X, Engelhardt NM, Park JJ, et al. Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation. Science Advances. 2026;12(16). doi:10.1126/sciadv.ady9895

BibTeX
@article{Wang2026,
  author = {Wang, Robert and Wang, Feng and DeBruyne, Nicole and Ji, Xinjun and Engelhardt, Nicole M and Park, Joseph Jee-Hwan and Notaro, Amber and Gaerlan, Samantha and Park, Ryan and Schultz, Matthew J and Clever, Sheila and McCormick, Elizabeth M and Keith, Kelsey and Ng, Bobby G and Kadash-Edmondson, Kathryn E and Freeze, Hudson H and Lam, Christina T and Morava, Eva and Helbig, Ingo and Falk, Marni J and Ganetzky, Rebecca D and Edmondson, Andrew C and Lin, Lan and Xing, Yi},
  title = {Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {16},
  doi = {10.1126/sciadv.ady9895}
}
Kostenlos starten →